XcelABLE, a global provider of Functional Capacity Evaluations (FCEs) and Independent Medical Examinations (IMEs), has partnered with Oculogica, developer of the EyeBOX concussion test. EyeBOX has the most FDA clearances of any concussion test, and is the subject of multiple peer-reviewed publications. It was the first concussion test cleared by FDA for use without a pre-injury baseline exam. The collaboration will make the EyeBOX test an integral component of all XcelABLE evaluations, giving employers, insurers, and attorneys access to objective data in traumatic brain injury (TBI) and concussion cases. Objective data for diagnosis of TBI and concussion is important for all concussion patients, including those in FCEs and IMEs. The partnership adds to the rigor of XcelABLE’s offering.
The partnership covers all 50 states and XcelABLE’s global partners. The partnership also supports XcelABLE’s ongoing multi-university studies on the biopsychosocial factors influencing concussion recovery.
About XcelABLE
XcelABLE delivers FCEs, IMEs, ergonomic assessments, and tele-occupational-medicine services through a credentialed clinician network globally. The woman-owned firm provides defensible reports in as little as 72 hours.
About Oculogica
Oculogica is a neuro-diagnostic company pioneering eye-tracking based diagnostics. EyeBOX was invented by a neurosurgeon, and is a breakthrough innovation for concussion testing. The test is fast, non-invasive, provides immediate results and has the industry’s broadest FDA label.